Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01124773 · ClinicalTrials.gov registry record
Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 1,362
- Enrollment target
NCT01124773: Completed study, sponsored by Wake Forest University Health Sciences.
NCT01124773 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,362 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01124773 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 1,362 participants
- Enrollment target
Study Summary
WHIMS-Y provides valuable information on the long-term effects on risk of cognitive impairment of hormone therapy in a subset of WHI participants in the WHI Hormone Trials. Following cessation of study-prescribed HT cognitive function and impairment were assessed.
Primary Outcome
Participants will have a cognitive assessment administered over the telephone.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,362 participants |
| Start Date | 2009-06 |
| Est. Completion | 2016-06 |
What the finished NCT01124773 record still lists
NCT01124773 is an observational study that tracks outcomes without assigning an intervention. Its 1,362 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01124773 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01124773 about?
NCT01124773 is a clinical study titled "Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm". WHIMS-Y provides valuable information on the long-term effects on risk of cognitive impairment of hormone therapy in a subset of WHI participants in the WHI Hormone Trials. Following cessation of study-prescribed HT cognitive function and impairment were assessed.
What is the current status of trial NCT01124773?
This trial is currently completed. The enrollment target is 1,362 participants. The study started on 2009-06. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT01124773?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia